Vapourtec, which designs and manufactures flow chemistry systems, is celebrating 10 years in business and being featured in 100 peer reviewed publications.
Founder Duncan Guthrie said: “It’s very pleasing to look back over the past decade and see the progress we’ve made.”
“We have sold our flow chemistry units to the top 10 global pharmaceutical companies with most returning to purchase multiple systems and in 2011 we established a strategic presence in Malaysia to service the Asian market which now represents our biggest area of growth.
“We have also become the first firm in our field to have been featured in 100 peer reviewed publications submitted by our customers and Vapourtec’s systems have recently played a key role in research that has identified more efficient manufacturing of key drugs including Tamoxifen for Breast Cancer.
“Flow chemistry as a process represents the future and we are actively involved in research with many major college and university chemistry departments around the world. It’s vital that we educate future generations of chemists as to the many advantages on using flow chemistry.
“These are very exciting times for Vapourtec with our systems continuing to be at the cutting edge of chemistry breakthroughs.”
Vapourtec’s customers come from a wide variety of sectors across the globe including education, pharmaceutical and industry and its technology has been cited as playing a pivotal part in recent major research breakthroughs.
Established in 2003, it has developed a flourishing international market for its technology with sales across much of the developed world including USA, China, Japan, Singapore and India.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here